Trial Profile
Pharmacokinetic Study of Two Oral Bemiparin Formulations.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Mar 2011
Price :
$35
*
At a glance
- Drugs Bemiparin sodium (Primary)
- Indications Catheter thrombosis; Deep vein thrombosis; Diabetic foot ulcer; Thromboembolism
- Focus Pharmacokinetics
- 16 Mar 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 16 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 May 2010 Planned end date changed from 1 Nov 2009 to 1 Nov 2010 as reported by ClinicalTrials.gov record.